Italy · Advertising framework
Email, SMS and direct-message marketing for aesthetic treatments in Italy
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Medical and dental information must respect professional limits
Regulator guidance
Article 56 addresses qualifications, professional activity, service characteristics and fees. Information must be accurate, clear and appropriate; comparative information needs measurable, reliable clinical indicators recognised by the scientific community. Do not present unvalidated innovations as established benefits. Additional statutory healthcare-advertising rules require review.
Sources: Medical Code of Ethics: Article 56
Review promotional pricing against the statutory healthcare limits
Editorial recommendation
The officially published 2023 amendment to article 1(525) excludes attractive or suggestive elements, including offers, discounts and promotions capable of causing inappropriate recourse to healthcare treatment. This is not a ban on every factual statement of fees: assess how the message affects informed choice and appropriateness of treatment.
The amendment text has now been checked directly in the Gazette. Retain a final consolidated-law check for the campaign date and apply the professional code and regional provider requirements separately.
Sources: Decree-law 69/2023, article 6 — healthcare communications; Medical Code of Ethics: Article 56 · Decree-law 69/2023, article 6; profession code article 56
Channel rules
Check the complete consumer-facing message
Regulator guidance
The EU consumer-protection framework addresses misleading actions and omissions, including an overall deceptive presentation and undisclosed commercial intent. Review benefits, risks, qualifications and prices as a whole under the national implementing law. Space limits do not provide an automatic exemption from material information requirements.
Sources: EU Unfair Commercial Practices Directive 2005/29/EC
Prior consent and the limited email customer exception
Regulator guidance
Electronic promotional contact normally needs prior consent. The soft-spam exception is limited to the sender’s own analogous offers using an address obtained in a sale, with appropriate information and an effective objection route. Do not extend that email exception automatically to SMS or social messaging.
Review personal data separately from the advertisement
Legal requirement — paraphrased
Identify an Article 6 basis for personal-data processing and an applicable Article 9 condition for health data. Provide appropriate transparency and honour the right to object to direct marketing. Permission to deliver healthcare does not automatically authorise advertising use of patient data; electronic contact and trackers also need their own local review.
Separate promotional and service messages
Editorial recommendation
Review the rules for the actual delivery method: email, SMS and private social messages are not interchangeable. Keep the relevant permission record, accurate sender details and a working suppression process.
Campaign workflow
Aesthetic Medicine & Cosmetic Procedures: prepare the review
Editorial recommendation
Separate the procedure, clinic, device, cosmetic and prescription medicine in the offer. Check restrictions on injectables and other products even when the headline advertises a consultation. Review realistic outcomes, risks, patient images and time-limited offers.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Separate the procedure, clinic, device, cosmetic and prescription medicine in the offer.
- Check restrictions on injectables and other products even when the headline advertises a consultation.
- Review realistic outcomes, risks, patient images and time-limited offers.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- The Gazette text of the 2023 healthcare-promotion amendment and the Ministry OTC/SOP application procedure are documented. A final consolidated-law check, regional provider conditions and exact authorised social-media functions remain necessary. AGCOM disclosure and registration thresholds do not replace healthcare advertising authorisation.
- This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates
An aesthetic campaign by email, SMS and direct messages in Italy can advertise a clinic while also implying claims about a procedure, device or prescription medicine. Separate those elements first, then review outcome images, risks and commercial pressure.
Email, SMS and private platform messages can follow different permission rules. Identify the delivery technology and the recipient relationship, then review the promotional content and withdrawal process separately.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. Italian medicine, device and medical-information baseline plus EU requirements. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- Medical Code of Ethics: Article 56
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- EU Unfair Commercial Practices Directive 2005/29/EC
EU framework implemented through national law; sector rules and local implementation also apply.
- Guidelines on promotional activities and spam
2013 guidance used only for the cited consent and email exception principles; check current Code and later decisions for implementation.
- EU General Data Protection Regulation 2016/679
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Decree-law 69/2023, article 6 — healthcare communications
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
From framework to action
Local expertise in Italy
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in Italy.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.